(EMAILWIRE.COM, October 10, 2019 ) Factors driving the growth of this market include increasing cancer research, high prevalence of cancer disorders, increasing research funding for the development of new cancer therapies, and increasing number of collaborations & acquisitions.

Hematopoietic cells segment is estimated to account for the largest share of the primary cells market in 2018.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

The objectives of this study are as follows:

# To define, describe, and forecast the primary cells market by origin, type, end user and region
# To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
# To identify micromarkets and the drivers, opportunities, and trends affecting the growth of the market
# To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
# To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
# To track and analyze competitive developments such as acquisitions; product launches, expansions; and R&D activities in the primary cells market

Primary Cells Market segmented into :

- By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung, renal, heart, skeletal & muscle, and other primary cells.

- Based on type, the market is segmented into human and animal primary cells. The human primary cells segment is expected to register the highest CAGR during the forecast period owing to the high adoption of human primary cells in the development of novel cancer therapies.

- On the basis of end user, the market is segmented into life science research companies and research institutes. The life science research companies segment is expected to grow at the highest CAGR during the forecast period.

Get Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960

The global primary cells market is dominated by North America, followed by Europe. North America will continue to dominate the global primary cells market during the forecast period, however, Asia is expected to witness the highest CAGR, with the growth in this market centered on China and Japan.